美股A股
StockGist
Back
8-K2026-03-19· x-ai/grok-4.1-fast

REVB · Revelation Biosciences, Inc.

0001193125-26-116012

SEC filing

Summary

Revelation Biosciences, Inc. held a Special Meeting on March 18, 2026, where stockholders approved the issuance of common stock pursuant to Class J Common Stock Warrants to exceed the Nasdaq Exchange Cap of 20% of outstanding shares. This approval sets the warrants' expiration date to March 18, 2031, enabling potential exercises without further stockholder consent.

Key takeaways